(EXPE) Expedia - Ratings and Ratios
Flights, Hotels, Car Rentals, Vacation Packages
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.55% |
| Yield on Cost 5y | 1.27% |
| Yield CAGR 5y | % |
| Payout Consistency | 59.3% |
| Payout Ratio | 10.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 38.7% |
| Value at Risk 5%th | 53.1% |
| Relative Tail Risk | -16.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.17 |
| Alpha | 40.38 |
| CAGR/Max DD | 1.50 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.301 |
| Beta | 1.453 |
| Beta Downside | 1.502 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.70% |
| Mean DD | 11.54% |
| Median DD | 11.46% |
Description: EXPE Expedia December 17, 2025
Expedia Group, Inc. (NASDAQ: EXPE) is a global online travel platform that operates through three primary segments: B2C (consumer-facing brands such as Expedia, Hotels.com, Vrbo, Orbitz, Travelocity, and others), B2B (technology and distribution services for airlines, travel agents, corporate travel managers, and financial institutions), and trivago (hotel-metasearch referrals). The company monetizes its ecosystem via bookings, brand advertising, loyalty programs, and mobile/app-based engagements, and it has been publicly traded under its current name since 2018.
Key recent metrics: 2023 total revenue reached approximately $10.5 billion, with adjusted EBITDA margin around 13 %-both reflecting a rebound from pandemic lows but still below pre-COVID peaks. The B2C segment now contributes roughly 55 % of revenue, while B2B accounts for about 30 % and trivago the remaining 15 %. Macro-level drivers include robust leisure travel demand as discretionary spending recovers, persistent inflation pressure on discretionary travel budgets, and a continued shift toward alternative-accommodation bookings (Vrbo’s market share grew ~8 % YoY in 2023). The sector is also sensitive to airline capacity constraints and currency fluctuations, which can affect both pricing power and cost structure.
For a deeper quantitative view, you might explore ValueRay’s analyst platform.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (1.39b TTM) > 0 and > 6% of Revenue (6% = 862.2m TTM) |
| FCFTA 0.14 (>2.0%) and ΔFCFTA 3.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -30.70% (prev -29.53%; Δ -1.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 3.77b > Net Income 1.39b (YES >=105%, WARN >=100%) |
| Net Debt (-784.0m) to EBITDA (2.79b) ratio: -0.28 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (131.0m) change vs 12m ago -3.48% (target <= -2.0% for YES) |
| Gross Margin 89.94% (prev 89.19%; Δ 0.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.24% (prev 57.23%; Δ 2.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.97 (EBITDA TTM 2.79b / Interest Expense TTM 240.0m) >= 6 (WARN >= 3) |
Altman Z'' -1.13
| (A) -0.18 = (Total Current Assets 12.85b - Total Current Liabilities 17.26b) / Total Assets 25.11b |
| (B) 0.06 = Retained Earnings (Balance) 1.54b / Total Assets 25.11b |
| (C) 0.08 = EBIT TTM 1.91b / Avg Total Assets 24.26b |
| (D) -0.67 = Book Value of Equity -15.11b / Total Liabilities 22.52b |
| Total Rating: -1.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 87.34
| 1. Piotroski 9.0pt |
| 2. FCF Yield 10.48% |
| 3. FCF Margin 24.93% |
| 4. Debt/Equity 4.85 |
| 5. Debt/Ebitda -0.28 |
| 6. ROIC - WACC (= 12.21)% |
| 7. RoE 115.6% |
| 8. Rev. Trend 65.40% |
| 9. EPS Trend 43.83% |
What is the price of EXPE shares?
Over the past week, the price has changed by +2.06%, over one month by +16.12%, over three months by +29.65% and over the past year by +54.43%.
Is EXPE a buy, sell or hold?
- Strong Buy: 13
- Buy: 3
- Hold: 20
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the EXPE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 271.1 | -6.3% |
| Analysts Target Price | 271.1 | -6.3% |
| ValueRay Target Price | 336.5 | 16.3% |
EXPE Fundamental Data Overview December 20, 2025
P/E Trailing = 27.54
P/E Forward = 15.8983
P/S = 2.4587
P/B = 25.9197
P/EG = 0.7993
Beta = 1.442
Revenue TTM = 14.37b USD
EBIT TTM = 1.91b USD
EBITDA TTM = 2.79b USD
Long Term Debt = 4.47b USD (from longTermDebt, last quarter)
Short Term Debt = 1.75b USD (from shortTermDebt, last quarter)
Debt = 6.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -784.0m USD (from netDebt column, last quarter)
Enterprise Value = 34.20b USD (35.33b + Debt 6.48b - CCE 7.61b)
Interest Coverage Ratio = 7.97 (Ebit TTM 1.91b / Interest Expense TTM 240.0m)
FCF Yield = 10.48% (FCF TTM 3.58b / Enterprise Value 34.20b)
FCF Margin = 24.93% (FCF TTM 3.58b / Revenue TTM 14.37b)
Net Margin = 9.66% (Net Income TTM 1.39b / Revenue TTM 14.37b)
Gross Margin = 89.94% ((Revenue TTM 14.37b - Cost of Revenue TTM 1.45b) / Revenue TTM)
Gross Margin QoQ = 91.48% (prev 90.04%)
Tobins Q-Ratio = 1.36 (Enterprise Value 34.20b / Total Assets 25.11b)
Interest Expense / Debt = 0.96% (Interest Expense 62.0m / Debt 6.48b)
Taxrate = 14.77% (167.0m / 1.13b)
NOPAT = 1.63b (EBIT 1.91b * (1 - 14.77%))
Current Ratio = 0.74 (Total Current Assets 12.85b / Total Current Liabilities 17.26b)
Debt / Equity = 4.85 (Debt 6.48b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = -0.28 (Net Debt -784.0m / EBITDA 2.79b)
Debt / FCF = -0.22 (Net Debt -784.0m / FCF TTM 3.58b)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.53% (Net Income 1.39b / Total Assets 25.11b)
RoE = 115.6% (Net Income TTM 1.39b / Total Stockholder Equity 1.20b)
RoCE = 33.73% (EBIT 1.91b / Capital Employed (Equity 1.20b + L.T.Debt 4.47b))
RoIC = 21.94% (NOPAT 1.63b / Invested Capital 7.43b)
WACC = 9.73% (E(35.33b)/V(41.81b) * Re(11.37%) + D(6.48b)/V(41.81b) * Rd(0.96%) * (1-Tc(0.15)))
Discount Rate = 11.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.77%
[DCF Debug] Terminal Value 65.06% ; FCFE base≈3.14b ; Y1≈2.85b ; Y5≈2.48b
Fair Price DCF = 234.2 (DCF Value 27.40b / Shares Outstanding 117.0m; 5y FCF grow -11.62% → 3.0% )
EPS Correlation: 43.83 | EPS CAGR: 68.92% | SUE: 3.13 | # QB: 1
Revenue Correlation: 65.40 | Revenue CAGR: 19.26% | SUE: 2.59 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.72 | Chg30d=-0.002 | Revisions Net=+5 | Analysts=15
EPS next Year (2026-12-31): EPS=17.82 | Chg30d=+0.166 | Revisions Net=+20 | Growth EPS=+17.7% | Growth Revenue=+7.3%
Additional Sources for EXPE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle